Cover Story is a new investigative podcast from New York Magazine. The first season, Power Trip, uncovers the secrets and exposes the darkest corners of the psychedelic renaissance through a twisted, deeply personal tale at the intersection of mind, body, and control. Power Trip is a co-production of New York Magazine and Psymposia.
New episodes of Power Trip will be released every Tuesday. Psymposia will discuss each episode on Plus Three every Sunday.
Psymposia, Inc. TAX ID: 85-0630940. Your donation is tax-deductible to the full extent allowed by law. For questions about donations, or to donate by check, wire, digital currency, or other means, please send us an email. To donate using PayPal click here.
Cover Story is a new investigative podcast from New York Magazine. The first season, Power Trip, uncovers the secrets and exposes the darkest corners of the psychedelic renaissance through a twisted, deeply personal tale at the intersection of mind, body, and control. Power Trip is a co-production of New York Magazine and Psymposia.
New episodes of Power Trip will be released every Tuesday. Psymposia will discuss each episode on Plus Three every Sunday.
Subscribe and listen to Power Trip on Apple, Spotify, or anywhere podcasts are available.
Cover Story is a new investigative podcast from New York Magazine. The first season, Power Trip, uncovers the secrets and exposes the darkest corners of the psychedelic renaissance through a twisted, deeply personal tale at the intersection of mind, body, and control. Power Trip is a co-production of New York Magazine and Psymposia.
New episodes of Power Trip will be released every Tuesday. Psymposia will discuss each episode on Plus Three every Sunday.
Listen on Spotify, Apple Podcasts, or wherever podcasts are available.
Psymposia is a 501(c)(3) non-profit media organization that offers leftist perspectives on drugs, politics, and culture. We are sustained by our readers and listeners who believe in the work we do. If you support our work please become a monthly donor on Patreon or make a one-time donation.
Psymposia, Inc. TAX ID: 85-0630940. Your donation is tax-deductible to the full extent allowed by law. For questions about donations, or to donate by check, wire, digital currency, or other means, please send us an email. To donate using PayPal click here.
Psymposia is a 501(c)(3) non-profit media organization that offers leftist perspectives on drugs, politics, and culture. We are sustained by our readers and listeners who believe in the work we do. If you support our work please become a monthly donor on Patreon or make a one-time donation.
Psymposia, Inc. TAX ID: 85-0630940. Your donation is tax-deductible to the full extent allowed by law. For questions about donations, or to donate by check, wire, digital currency, or other means, please send us an email. To donate using PayPal click here.
Top Stories
New Website Details Abuse Allegations Against German Psychedelic Practitioners
A new website — whoisjoeschraube.com — alleges that Joe Schraube and Miguel Delgado have taken advantage of positions of power and abused people under the influence of psychedelics.
MAPS Canada’s Data Breach Foreshadows Corporadelic Future
As the psychedelic pharmaceutical industry increasingly prioritizes personal data extraction through mobile apps, wearables, and so-called “targeted” medicine, a recent data breach by former MAPS Canada Executive Director Mark Haden provides a warning about some of the possible consequences to the financial incentives of datafication.
Top Stories
COMPASS Pathways’ Psilocybin Patent Questioned By UK Patent Examiner
While COMPASS has issued a response defending the validity of its patents, one of the co-inventors says the patent examiner’s opinion is probably “a valid one.”
COMPASS Pathways Is Trying to Patent Psilocybin for More Mental Health Conditions Than You Can Name
by Russell Hausfeld and David Nickles
News that COMPASS Pathways is attempting to patent psychedelic therapy room specifications and therapist behaviors started an online firestorm about the company’s “monopolistic and shady behaviors,” but so far the debates have missed the biggest threats lurking in COMPASS’s international patent applications.
Top Stories
New Website Details Abuse Allegations Against German Psychedelic Practitioners
A new website — whoisjoeschraube.com — alleges that Joe Schraube and Miguel Delgado have taken advantage of positions of power and abused people under the influence of psychedelics.
MAPS Canada’s Data Breach Foreshadows Corporadelic Future
As the psychedelic pharmaceutical industry increasingly prioritizes personal data extraction through mobile apps, wearables, and so-called “targeted” medicine, a recent data breach by former MAPS Canada Executive Director Mark Haden provides a warning about some of the possible consequences to the financial incentives of datafication.
Top Stories
New Website Details Abuse Allegations Against German Psychedelic Practitioners
A new website — whoisjoeschraube.com — alleges that Joe Schraube and Miguel Delgado have taken advantage of positions of power and abused people under the influence of psychedelics.
MAPS Canada’s Data Breach Foreshadows Corporadelic Future
As the psychedelic pharmaceutical industry increasingly prioritizes personal data extraction through mobile apps, wearables, and so-called “targeted” medicine, a recent data breach by former MAPS Canada Executive Director Mark Haden provides a warning about some of the possible consequences to the financial incentives of datafication.
Join Our Newsletter
Independent reporting. Critical analysis. In your inbox.
Join Our Newsletter
Independent reporting. Critical analysis. In your inbox.
#47 – Part Two: Right Wing Psychedelia
We continue our discussion about Brian Pace and Neşe Devenot's recently published paper: "Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency"
#46 – Part One: Right Wing Psychedelia
We discuss Brian Pace and Neşe Devenot's recently published paper: "Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency"
Livestream – November 19, 2020
We kicked off the start of our ongoing livestreams with the announcement of Psymposia's 501(c)(3) non-profit status, discussions of corporadelic dynamics, fond memories of helping people learn how to extract psychedelic drugs during an Ivy League University's psychedelic conference, and a whole bunch of back and forth with the audience about the current state (and future) of psychedelia.
Chemical Poetics: Rebel Wisdom and the Psychedelic IDW
Neşe Devenot, PhD of Psymposia’s Plus Three podcast ventures into the psychedelic “arm” of the Intellectual Dark Web in this first episode of Chemical Poetics.
Series
A series exploring the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry.
Join Our Newsletter
Independent reporting. Critical analysis. In your inbox.
Become a member.
Support Us On Patreon.
A six part series on the intersection of psychedelics and capitalism, and the early investors making it happen.
From Mining to Mushrooms
A series exploring the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry.
Livestream – November 19, 2020
We kicked off the start of our ongoing livestreams with the announcement of Psymposia's 501(c)(3) non-profit status, discussions of corporadelic dynamics, fond memories of helping people learn how to extract psychedelic drugs during an Ivy League University's psychedelic conference, and a whole bunch of back and forth with the audience about the current state (and future) of psychedelia.
The LSD Silo Bust according to William Leonard Pickard
Neşe Devenot shares William Leonard Pickard's description of his side of the Silo bust in "The Rose of Paracelsus."
Corporadelic
A series on the intersection of psychedelics and capitalism, and the early investors making it happen.
Corporadelic
A series on the intersection of psychedelics and capitalism, and the early investors making it happen.
Talking Psychedelic Capitalism in a WeWork Ballroom
Psychedelic capitalists justify their decision to go for-profit in the ballroom of America’s most recent for-profit flop.
